Clinical Trials Browser

Epstein-Barr Virus Infections × 90 days × Clear all

NCT02135042 2026-03-18

Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA

Phase 2/3 Active not recruiting

Nasopharyngeal Carcinoma, Epstein-Barr Virus Infections

NCT07478952 2026-03-18

A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189 in Healthy Adults 18 to 30 Years of Age

Phase 1 Not yet recruiting

Epstein-Barr Virus Infections

NCT03258567 2026-03-06

Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas

Phase 2 Recruiting

Lymphoma, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT06908096 2026-03-06

Epstein-Barr Virus (EBV) gH/gL/gp42-Ferritin Nanoparticle Vaccine With or Without gp350-Ferritin in Healthy Adults With or Without EBV Infection

Phase 1 Recruiting

Infectious Mononucleosis, Epstein-Barr Virus Infections

NCT03394365 2026-02-20

ALLELE

Phase 3 Recruiting

Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT04554914 2026-02-20

A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Phase 2 Recruiting

LymphoidSarcoma

Immunologic Deficiency Syndromes, Leiomyosarcoma, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

NCT05389423 2026-02-19

Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas

Phase 1 Recruiting

Plasmablastic Lymphoma, Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Epstein-Barr Virus Infections

NCT00032513 2026-02-17

Genetic Studies of Chronic Active Epstein-Barr Disease

Herpes Simplex, Infectious Mononucleosis, Lymphoproliferative Disorders, Virus Diseases, Epstein-Barr Virus Infections

NCT06761677 2026-02-05

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Phase 1/2 Suspended

LymphoidOther hematologic neoplasm

Immunoblastic Lymphadenopathy, Lymphoma, Recurrence, Leukemia-Lymphoma, Adult T-Cell, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Epstein-Barr Virus Infections, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT07368634 2026-01-28

Exploratory Study of EBV-TCR-T Cell Injection for EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation

Phase 1/2 Recruiting

Epstein-Barr Virus Infections

NCT07368153 2026-01-26

IDEP

Phase 2 Not yet recruiting

Epstein-Barr Virus Infections

NCT07358910 2026-01-22

RACSMEI

10,000 enrolled

Classical hematology

Zika Virus Infection, Vaccine-Preventable Diseases, Vector Borne Diseases, Severe Fever with Thrombocytopenia Syndrome, Adenoviridae Infections, Arenaviridae Infections, Brucellosis, Bunyaviridae Infections, Chickenpox, Chlamydia Infections, Communicable Diseases, Dengue, Elephantiasis, Filarial, Encephalitis, Japanese, Encephalitis, Tick-Borne, Enterovirus Infections, Giardiasis, Hepatitis A, Leishmaniasis, Leptospirosis, Malaria, Measles, Melioidosis, Meningitis, Mumps, Mycoplasma Infections, Parvoviridae Infections, Q Fever, Rift Valley Fever, Rotavirus Infections, Rubella, Schistosomiasis, Tetanus, Trichuriasis, Whooping Cough, Yellow Fever, Zoonoses, Hepatitis E, Caliciviridae Infections, Hantavirus Infections, Epstein-Barr Virus Infections, Henipavirus Infections, Neglected Diseases, Chikungunya Fever